Custom smartwatch tracks sedate levels inside the body continuously Kumar Jeetendra | August 8, 2020 Engineers in the UCLA Samueli School of Engineering and their colleagues at Stanford School of Medicine have demonstrated that drug levels inside the body is able to be tracked in real time using a custom smartwatch which assesses the compounds found in sweat. This wearable technology can be incorporated into a more personalized approach to …
Researchers distinguish cell structure that may assume basic job in coronavirus replication Kumar Jeetendra | August 8, 2020 Scientists have identified a structure in host cells which the novel coronavirus likely uses to synthesise elements that will be assembled into completely infectious germs, an advance that might lead to the development of new medications against COVID-19. The analysis, published in the journal Science Advances, uncovers a coronavirus-specific structure in cells, which might work …
Relief Therapeutics sees 60-70% possibility of COVID-19 medication endorsement Kumar Jeetendra | August 8, 2020 Relief Therapeutics’ chairman said that he was optimistic that its RLF-100 (aviptadil) drug will acquire approval for treating COVID-19 patients in a matter of months. The Swiss group owns the rights to the drug in the United States and Europe. Its US spouse NeuroRx is conducting multicentre clinical trials in patients that are severely ill …
Jubilant Life Sciences presents 1,000 vials of Remdesivir to Uttar Pradesh CM Yogi Adityanath Kumar Jeetendra | August 8, 2020 Drug firm Jubilant Life Sciences on Saturday said it has introduced 1,000 vials of antiviral drug Remdesivir that it sells under the brand name’JUBI-R’ into Uttar Pradesh Chief Minister Yogi Adityanath. The drug has been made accessible to over 1,000 hospitals supplying COVID-19 treatment in India throughout the organization’s distribution system, Jubilant Life Sciences said …
Researchers disentangle how safe immune system glitches in extreme COVID-19 cases Kumar Jeetendra | August 7, 2020 Unlike earlier studies, scientists have found that severe COVID-19 does not solely bring about a hyperactive immune system, but instead the body’s defense response is captured in a constant loop of activation and inhibition, an advance that may help develop superior therapeutics to combat the deadly illness. The researchers, such as those from the Center …
BD Extended HPV Testing Gets FDA Approval Kumar Jeetendra | August 7, 2020 BD (Becton, Dickinson and Company), Franklin Lakes, NJ, received a premarket approval (PMA) supplement in the FDA for an Enlarged version of its BD Onclarity human papillomavirus (HPV) assay. The PMA supplement comprises the expansion for genotype reporting past HPV genotypes 16, 18, and 45 to comprise types 31, 51, 52, 33/58, 35/39/68, and 56/59/66, …
Biomedical scientists make counterfeit organelles to control biological function in cells Kumar Jeetendra | August 7, 2020 Biomedical engineers at Duke University have shown a way of controlling the phase separation of an emerging class of proteins to create artificial membrane-less organelles in human cells. The progress, similar to controlling how vinegar forms droplets within oil, creates chances for engineering artificial structures to modulate present cell functions or produce entirely new behaviours …
Covid-19 Antibody Rapid Serology Test by Americal Screening Kumar Jeetendra | August 6, 2020 American Idol, Shreveport, La, has included a covid-19 IgG/IgM rapid test to its inventory. The in vitro immunoassay, that has been allowed emergency use authorization (EUA) from the FDA, is created for the qualitative and direct discovery of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is simple to …
New medication RLF-100 shows sensational outcomes for basic COVID-19 patients Kumar Jeetendra | August 6, 2020 Doctors in a hospital have used a brand new drug called RLF-100, also called aviptadil, which has resulted in rapid recovery from respiratory failure in critically ill COVID-19 patients. The drug has been approved by the FDA for emergency use at multiple clinical sites in patients that are too sick to input the FDA’s Stage …
UCI researchers develop novel molecule for COVID-19 treatment Kumar Jeetendra | August 6, 2020 When the coronavirus pandemic struck, nearly everyone in the University of California, Irvine — and colleges across the country — had to abandon campus. That’s because his laboratory, which designs and constructs chemical molecules, had the ideal equipment to aid in the international push to locate remedies for COVID-19. Nowick’s group set to work in …
Quicker Test for Covid-19 Antibodies Kumar Jeetendra | August 5, 2020 A team of Swiss-German researchers has developed a method of testing for neutralizing antibodies against SARS-CoV-2 that creates a result in half the time of traditional tests. A conventional neutralization test to determine immunity to SARS-CoV-2 usually takes two to three days and has to be carried out with infectious coronaviruses in a lab resorting …
BioNTech, Fosun Pharmaceutical dispatch another COVID-19 vaccine trial Kumar Jeetendra | August 5, 2020 Germany’s BioNTech and China’s Shanghai Fosun Pharmaceutical on Wednesday declared the start of another COVID-19 vaccine trial in China with a total of 144 participants. “The study is designed to support the regulatory approval process for the Chinese market and plans to confirm the safety and immunogenicity profile observed in participants in the German and …
